ALLOGENE THERAPEUTICS INC's ticker is and the CUSIP is 019770956. A total of 4 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,032 | -13.1% | 89,600 | +36.2% | 0.00% | 0.0% |
| Q2 2023 | $327,026 | +65.5% | 65,800 | +64.5% | 0.00% | 0.0% |
| Q1 2023 | $197,600 | +7753.7% | 40,000 | +9900.0% | 0.00% | – |
| Q4 2022 | $2,516 | -93.5% | 400 | -88.9% | 0.00% | – |
| Q3 2022 | $39,000 | +550.0% | 3,600 | +620.0% | 0.00% | – |
| Q2 2022 | $6,000 | -50.0% | 500 | -61.5% | 0.00% | – |
| Q1 2022 | $12,000 | -98.4% | 1,300 | -97.4% | 0.00% | -100.0% |
| Q4 2021 | $759,000 | +25200.0% | 50,900 | +50800.0% | 0.00% | – |
| Q3 2021 | $3,000 | -95.6% | 100 | -96.2% | 0.00% | – |
| Q2 2021 | $68,000 | +871.4% | 2,600 | +1200.0% | 0.00% | – |
| Q1 2021 | $7,000 | -46.2% | 200 | -60.0% | 0.00% | – |
| Q4 2020 | $13,000 | -43.5% | 500 | -16.7% | 0.00% | – |
| Q3 2020 | $23,000 | -70.1% | 600 | -66.7% | 0.00% | – |
| Q2 2020 | $77,000 | -63.3% | 1,800 | -77.8% | 0.00% | -100.0% |
| Q4 2019 | $210,000 | +4100.0% | 8,100 | +3950.0% | 0.00% | – |
| Q3 2019 | $5,000 | -81.5% | 200 | -80.0% | 0.00% | – |
| Q2 2019 | $27,000 | +800.0% | 1,000 | +900.0% | 0.00% | – |
| Q1 2019 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 40,000 | $197,600 | 0.00% |
| SIMPLEX TRADING, LLC | 134,900 | $666 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 16,700 | $82,498 | 0.00% |